All stock lists
Utah Medical Products Inc (NASDAQ:UTMD)
US · Delayed Price · Currency is USD
Healthcare · Medical - Instruments & Supplies
66.80-2.04 (-2.96%)
Insider Score
/ 99
UTMD Insider Score
UTAH MEDICAL PRODUCTS INC has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
Unlock UTMD’s Insider ScoreFinancial Health Score
Strong
From UTMD’s reported statements · Q3 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $34.9M
- Net income
- $10.6M
- Net margin
- 30.5%
Leverage20 / 20
Little or no net debt.
- Total debt
- $180K
- Cash
- $85.2M
- Net debt / EBITDA
- -5.72x
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $100.6M
- Current liabilities
- $4.7M
- Current ratio
- 21.23
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $8.0M
- Free cash flow
- $7.6M
- FCF margin
- 21.8%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 3.2M
- Share growth (1y)
- -0.8%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
UTMD Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 8.62 M | 8.53 M | 8.72 M | 9.04 M | 9.81 M | 9.95 M |
| Revenue Growth (YoY) | -12.14 % | -14.31 % | -10.18 % | -1.23 % | -1.93 % | -4.30 % |
| Cost of Revenue | 3.78 M | 3.77 M | 3.44 M | 3.78 M | 4.21 M | 4.36 M |
| Gross Profit | 4.84 M | 4.76 M | 5.28 M | 5.26 M | 5.60 M | 5.59 M |
| SG&A Expense | 1.90 M | 1.96 M | 2.56 M | 2.61 M | 2.83 M | 2.26 M |
| R&D Expense | 142.00 K | 154.00 K | 154.00 K | 212.00 K | 167.00 K | 135.00 K |
| Operating Expenses | 2.04 M | 2.11 M | 2.72 M | 2.82 M | 2.99 M | 2.40 M |
| Operating Income | 2.79 M | 2.65 M | 2.56 M | 2.44 M | 2.61 M | 3.20 M |
| Pretax Income | 3.40 M | 3.29 M | 3.18 M | 3.11 M | 3.31 M | 3.84 M |
| Tax Provision | 614.00 K | 600.00 K | 578.00 K | 540.00 K | 678.00 K | 788.00 K |
| Net Income | 2.79 M | 2.69 M | 2.60 M | 2.57 M | 2.63 M | 3.05 M |
| EPS (Basic) | 0.88 | 0.84 | 0.82 | 0.80 | 0.82 | 0.94 |
| EPS (Diluted) | 0.88 | 0.84 | 0.82 | 0.80 | 0.82 | 0.94 |
| Shares Outstanding | 3.18 M | 3.18 M | 3.19 M | 3.20 M | 3.21 M | 3.25 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.